ALSO NOTED: Sativex wins nod; EU puts Viracept on hold; Publix offers free drugs

> Canadian regulators have given a conditional nod to Sativex, the marijuana-based remedy for cancer pain developed by GW Pharmaceuticals and jointly developed and marketed with Bayer. GW Pharma's shares were up on the news. Report

> The EU has put Roche's license to sell HIV drug Viracept on hold, following the med's withdrawal from the market in June. Batches of Viracept had been contaminated with ethyl mesilate, a DNA-damaging substance and possible carcinogen. Report

> Forget everyday low prices for generics. Try free drugs. Publix Super Markets announced that it will hand out 14-day supplies of seven top antibiotics, including amoxicillin, erythromycin, and ciprofloxacin. Prescriptions required, of course. Report 

And Finally... At BrandweekRx, Jim Edwards outlines 10 direct-to-consumer advertising reforms he says are urgently needed to protect consumers from unscrupulous drug advertising. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.